Last Updated: June 25, 2026

Zinc acetate - Generic Drug Details

Name: zinc acetate Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for zinc acetate and what is the scope of freedom to operate?

Zinc acetate is the generic ingredient in one branded drug marketed by Eton and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for zinc acetate

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	95
Clinical Trials:	1,437
What excipients (inactive ingredients) are in zinc acetate?	zinc acetate excipients list
DailyMed Link:	zinc acetate at DailyMed

Recent Clinical Trials for zinc acetate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Guiying Wang	PHASE2
Trust Fertility Clinic	PHASE4
Second Xiangya Hospital of Central South University	PHASE1

See all zinc acetate clinical trials

Pharmacology for zinc acetate

Drug Class	Copper Absorption Inhibitor
Physiological Effect	Decreased Copper Ion Absorption

Anatomical Therapeutic Chemical (ATC) Classes for zinc acetate

A16AX	Various alimentary tract and metabolism products
A16A	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for zinc acetate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eton	GALZIN	zinc acetate	CAPSULE;ORAL	020458-002	Jan 28, 1997		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Eton	GALZIN	zinc acetate	CAPSULE;ORAL	020458-001	Jan 28, 1997		RX	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.